Clinical Trial Results:
Estudio multicéntrico, doble ciego, aleatorizado, con grupos paralelos, de dosis escalonada para evaluar la eficacia y la seguridad de 2,5 mg, 10 mg, 35 mg y 50 mg de AVE7688 una vez al día, utilizando 100 mg de losartán potásico una vez al día como control activo, durante 12 meses de tratamiento en pacientes con hipertensión leve a moderada.
Summary
|
|
EudraCT number |
2005-003521-13 |
Trial protocol |
ES PT DE IT |
Global completion date |
20 Mar 2008
|
Paediatric regulatory details
|
|
Is the trial part of an agreed EMA paediatric investigation plan? |
No
|
Is the trial in scope of article 45 of Regulation (EC) No 1901/2006? |
No
|
Is the trial in scope of article 46 of Regulation (EC) No 1901/2006? |
No
|
Results information
|
|
Results version number |
v1(current) |
This version publication date |
29 Oct 2016
|
First version publication date |
29 Oct 2016
|
Other versions |
|
Summary report(s) |
DFI6032 |
Note: The legislation allows summary attachments to be posted instead of the full dataset for this trial. Refer to Commission Guideline 2012/C 302/03
for further information.